Aduhelm™ (aducanumab) – New drug approval
On June 7, 2021, the FDA announced the controversial approval of Biogen’s Aduhelm (aducanumab), for the treatment of Alzheimer’s disease.
Menu
We share important prescription drug information to help you stay informed about updates concerning particular prescription medicines.
On June 7, 2021, the FDA announced the controversial approval of Biogen’s Aduhelm (aducanumab), for the treatment of Alzheimer’s disease.
12000 Biscayne Blvd, Suite 800
Miami, FL 33181
TF: 888-488-5750
F: 786-254-7695
12000 Biscayne Blvd, Suite 800 Miami, FL 33181
TF: 888-488-5750 | F: 786-254-7695